Welcome to our dedicated page for Maxlinear SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to MaxLinear, Inc. (Nasdaq: MXL) SEC filings, offering a structured view of the company’s regulatory disclosures as a U.S. public issuer. MaxLinear operates in the semiconductor and related device manufacturing industry, supplying RF, analog, digital and mixed-signal integrated circuits for connectivity, infrastructure, and industrial and multi-market applications.
Through its filings with the U.S. Securities and Exchange Commission, MaxLinear reports financial results, material events, and risk factors. Current reports on Form 8‑K have disclosed unaudited quarterly financial results, including net revenue, margins, operating expenses, and earnings measures, as well as the authorization of a share repurchase program that allows the company to buy back a specified amount of its common stock over a multi-year period. These 8‑K filings often incorporate related press releases by reference.
Investors can use this filings page to locate MaxLinear’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which typically contain detailed discussions of the company’s business, segment information, risk factors, management’s discussion and analysis, and notes to the financial statements. The risk factor sections elaborate on topics highlighted in press releases, such as competition in the semiconductor industry, market cyclicality, trade and tariff issues, geopolitical conditions, customer demand variability, legal proceedings, and technology and cybersecurity considerations.
In addition to periodic reports, users can review Forms 8‑K for announcements about financial results, share repurchase authorizations, and other significant events. Where applicable, insider transaction reports on Form 4 and proxy statements on Schedule 14A can provide further insight into executive and director share ownership, equity awards, and governance matters. Stock Titan’s interface is designed to surface these filings as they are made available through EDGAR and to pair them with AI-powered summaries that explain key points, highlight important changes, and help readers interpret complex sections of lengthy documents such as 10‑K and 10‑Q reports.
MaxLinear, Inc. director Ted L. Tewksbury III amended his earlier Form 4 to report an award of 15,741 restricted stock units (RSUs). Each RSU converts to one share of common stock and the amendment corrects the previously reported RSU count. The RSUs were granted on
MaxLinear insider Connie Kwong reported receipt of shares from RSU vesting and related withholdings. On 09/01/2025 Ms. Kwong received 58,909 shares of MaxLinear common stock as restricted stock units settled upon vesting. The filing also shows 58,152 shares were disposed of at a reported price of $15.72 (reflecting shares withheld to satisfy tax/withholding obligations). After the transactions, Ms. Kwong directly beneficially owns the delivered shares and retains 2,126 RSUs that remain subject to future vesting through August 20, 2026.
Steven G. Litchfield, Chief Financial Officer and Chief Corporate Strategy Officer of MaxLinear, Inc. (MXL), reported two dispositions on August 26, 2025. The filing shows sale of 100,880 shares at a weighted-average price of $17.2779 (range $17.16–$17.43) and an additional sale of 1,277 shares at $17.325. After these transactions the reporting person beneficially owned 312,203 shares (the filing lists 313,480 after the larger sale and 312,203 after the second sale). The report was signed by an attorney-in-fact on August 27, 2025.
MaxLinear, Inc. (MXL) filed a Form 144 notifying a proposed sale of 102,157 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,765,108.49. The filing lists approximately 87,080,498 shares outstanding and an approximate sale date of 08/26/2025. The securities to be sold were acquired in three grants: 1,277 shares via an Employee Stock Purchase Plan on 05/17/2021, 47,725 restricted shares on 02/22/2019, and 53,155 performance shares on 02/17/2021. No sales by the seller were reported in the past three months. The signer certifies they have no undisclosed material adverse information about the issuer.
State Street Corporation reports beneficial ownership of 4,302,294 shares of MaxLinear Inc. common stock, representing 5% of the outstanding class. The filer discloses no sole voting or dispositive power; instead it reports shared voting power of 4,051,581 shares and shared dispositive power of 4,302,294 shares, indicating the position is managed collectively across accounts. The filing states the securities are held in the ordinary course of business and were not acquired to change or influence control. Several State Street advisory subsidiaries are named as the relevant holders, including SSGA Funds Management, State Street Global Advisors Europe Limited, State Street Global Advisors Limited and State Street Global Advisors Trust Company.
Form 4 — MaxLinear, Inc. (MXL): Steven G. Litchfield
The filing reports insider equity awards for Steven G. Litchfield (Chief Financial Officer and Chief Corporate Strategy Officer). On 07/27/2025 an outstanding option was amended: the "old" option (originally granted 08/10/2018, fully vested on 07/02/2022) was cancelled and a replacement option was granted. The replacement option covers 306,000 shares with an exercise price of $18.40, exercisable on 08/10/2025 and expiring 08/10/2028. Additionally, 77,760 Restricted Stock Units (RSUs) were granted on 08/04/2025, each representing one share, vesting one-third on 05/20/2026 and annually thereafter to full vesting on 05/20/2028. The form is signed by Connie Kwong as attorney-in-fact on 08/05/2025.